RA CAPITAL MANAGEMENT, L.P. – Relmada Therapeutics, Inc. Transaction History
RA CAPITAL MANAGEMENT, L.P. portfolio value:
$74.04M
portfolio value
RA CAPITAL MANAGEMENT, L.P. quarter portfolio value change:
+94.94%
quarter
Relmada Therapeutics, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | 0.00% | 0 shares | 36.06M | $37.02 | 2M | |
Q2 2022 | share | 0.00% | 0 shares | -16M | $18.99 | 2M | |
Q1 2022 | share | 0.00% | 0 shares | 8.92M | $26.99 | 2M | |
Q4 2021 | share | Increase | 0.00% | 2M shares | 45.06M | $21.71 | 2M |
Q4 2020 | share | Decrease | -100.00% | -781.29K shares | -29.39M | $32.07 | 0 |
Q3 2020 | share | Decrease | -8.29% | -70.61K shares | -8.73M | $37.62 | 781.29K |
Q2 2020 | share | Decrease | -38.27% | -528.08K shares | -8.94M | $44.75 | 851.90K |
Q1 2020 | share | Increase | +81.18% | 618.32K shares | 17.36M | $34.11 | 1.37M |
Q4 2019 | share | Increase | 0.00% | 761.66K shares | 29.70M | $39 | 761.66K |